3.0.0 2051 2022-11-01T13:50:47Z 2022-11-01T13:50:47Z Senate S 2019-06-28 116 ssfi00 Finance Committee Senate Standing Referred to 2019-06-28T16:45:16Z Prescription Drug STAR Act 116 2113 HR 2020-12-24 Placed on the Union Calendar, Calendar No. 571. Related bill CRS More Efficient Tools to Realize Information for Consumers Act 116 2296 HR 2019-09-24 Placed on the Union Calendar, Calendar No. 170. Related bill CRS Lower Costs, More Cures Act of 2019 116 19 HR 2019-12-19 Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. Related bill CRS Drug Price Transparency Act 116 2087 HR 2019-05-21 Subcommittee Hearings Held. Related bill CRS Lower Costs, More Cures Act of 2019 116 3129 S 2019-12-19 Read twice and referred to the Committee on Finance. Related bill CRS Removing Barriers to Colorectal Cancer Screening Act of 2020 116 1570 HR 2020-12-10 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2019-06-28 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2019-06-28 Introduced in Senate IntroReferral 10000 9 Library of Congress M000639 Sen. Menendez, Robert [D-NJ] Robert Menendez D NJ N Y000064 Sen. Young, Todd [R-IN] Todd Young R IN C. 2019-06-28 True Health Administrative law and regulatory procedures Civil actions and liability Congressional oversight Consumer affairs Health care costs and insurance Health information and medical records Insurance industry and regulation Medicare Prescription drugs Retail and wholesale trades Health 00 2019-06-28 Introduced in Senate 2020-07-30T19:05:25Z Strengthening Average Sales Price Reporting Act of 2019

This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

]]> Strengthening Average Sales Price Reporting Act of 2019 Display Title Strengthening Average Sales Price Reporting Act of 2019 Short Title(s) as Introduced Strengthening Average Sales Price Reporting Act of 2019 Introduced in Senate IS Official Title as Introduced A bill to amend XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program. Introduced in Senate IS Introduced in Senate 2019-06-28T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s2051is/xml/BILLS-116s2051is.xml 2019-06-28 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.